Clinical Study
Cushing’s Disease: The Relevance of a Combined Dexamethasone Desmopressin Test as a Component of Postoperative Hormonal Evaluation
Table 4
Relative (Δ%) changes in cortisol and ACTH levels at consecutive time points versus baseline, stratified by remission status.
| | Remission () | Persistent CD () | value | | Mean ± SD | Median | Range | Mean ± SD | Median | Range |
| Cortisol (μg/dL) | | | | | | | | 15′ | 32.0 ± 99.6 | 0.0 | −2.2–389.5 | 185.0 ± 180.8 | 119.1 | 1.9–514.8 | <0.001 | 30′ | 35.0 ± 106.6 | 7.9 | −16.7–417.5 | 265.6 ± 253.7 | 175.2 | 9.7–854.9 | <0.001 | 60′ | 23.3 ± 70.6 | 0.0 | −14.2–274.1 | 290.3 ± 274.6 | 191.3 | 11.0–912.3 | <0.001 | 90′ | 17.9 ± 47.3 | 0.0 | −15.8–179.7 | 262.5 ± 261.8 | 151.9 | −5.3–723.8 | <0.001 | 120′ | 9.7 ± 37.6 | 0.0 | −10.8–144.8 | 223.3 ± 249.9 | 124.0 | −17.4–788.6 | <0.001 | ACTH (pg/mL) | | | | | | | | 15′ | 143.4 ± 129.9 | 100.0 | 0.0–433.3 | 539.1 ± 882.0 | 177.8 | 5.3–2602.4 | 0.121 | 30′ | 91.0 ± 103.7 | 46.7 | −25.0–300.0 | 461.7 ± 673.2 | 157.9 | 15.8–2042.9 | 0.024 | 60′ | 27.5 ± 61.2 | 26.7 | −50.0–166.7 | 231.8 ± 317.0 | 91.7 | 5.3–1095.2 | 0.004 | 90′ | 11.4 ± 54.9 | 0.0 | −63.6–133.3 | 156.1 ± 256.7 | 53.1 | 10.5–950.0 | 0.004 | 120′ | 1.5 ± 42.6 | 0.0 | −50.0–100.0 | 119.0 ± 241.7 | 10.5 | −22.2–840.5 | 0.011 |
|
|